CVR 31846803Public limited company (A/S)Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)FredericiaFounded 31 Oct 2008
Employees
1,000
Annual report 2025, average
Revenue
21K
DKK, annual report 2025
-99.8% on 2024
Result
-503.9M
DKK, annual report 2025
Equity
73.5M
DKK, annual report 2025
Compiled by Dandex from the Central Business Register (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish company data. Connect it once and ask about Renescience A/S, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set Up DandexØrsted New Bio Solutions Holding A/SCVR 32319017, 100% of capital and votes, since 24 Apr 2013
Thomas Søndergaard Lysesince 10 Aug 2026
CVR 32319017100% of capital and votessince 24 Apr 2013
Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.
Ultimate controller
Finansministeriet, Departementet
CVR 10108330Statslig administrativ enhed
Holds 50% to under 66.7% of capital and votes in Ørsted A/S, since 20 Feb 2014
Holding company
CVR 36213728Public limited company (A/S)
Holds 100% of capital and votes in Ørsted Bioenergy & Thermal Power A/S, since 9 Jun 2006
Holding company
Ørsted Bioenergy & Thermal Power A/S
CVR 27446469Public limited company (A/S)
Holds 100% of capital and votes in Ørsted New Bio Solutions Holding A/S, since 24 Apr 2013
Holding company
Ørsted New Bio Solutions Holding A/S
CVR 32319017Public limited company (A/S)
Holds 100% of capital and votes in Renescience A/S, since 24 Apr 2013
This company
Renescience A/S
CVR 31846803
CVR records founders at incorporation. It does not record whether they are alive or still involved.
15 Apr 2016 to 3 Nov 2026.
31 Oct 2008 to 3 Nov 2026.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 7,970 | 10,831 | 10,419 | 10,836 | 21 |
| Operating profit | -12,015 | -12,708 | -36,452 | -17,785 | -6,163 |
| Result for the year | -8,322 | -13,301 | -194,649 | -23,904 | -503,937 |
| Equity | 22,754 | 182,960 | -11,689 | 7,407 | 73,470 |
| Total assets | 35,921 | 217,391 | 32,791 | 14,580 | 81,310 |
| Employees (average) | Not reported | 0 | 0 | 1,000 | 1,000 |
| Credit metrics (Dandex calculations) | |||||
| Revenue growth (omsætningsvækst) | 371.6% | 35.9% | -3.8% | 4% | -99.8% |
| EBIT margin (overskudsgrad) | -150.8% | -117.3% | -349.9% | -164.1% | -29,347.6% |
| EBITDA | -11,401 | -10,887 | -13,537 | -15,360 | -6,163 |
| EBITDA margin | -143.1% | -100.5% | -129.9% | -141.8% | -29,347.6% |
| Employee growth (vækst i antal ansatte) | Not reportednote 1 | n.m.note 2 | Not reportednote 3 | n.m.note 2 | 0% |
| Net interest-bearing debt (NIBD, nettorentebærende gæld) | Not reportednote 4 | Not reportednote 4 | 11,482 | Not reportednote 4 | Not reportednote 5 |
| Capex (investeringer i anlægsaktiver) | 316note 6 | 330note 7 | 11,446note 7 | 530note 7 | Not reportednote 8 |
| Capex % of sales (investeringer i procent af omsætningen) | 4%note 6 | 3.1%note 7 | 109.9%note 7 | 4.9%note 7 | Not reportednote 8 |
| NIBD incl. group and owner balances (NIBD inkl. koncern- og ejermellemværender) | Not reportednote 4 | Not reportednote 4 | 39,831 | Not reportednote 4 | Not reportednote 5 |
DKK thousands. Annual reports via XBRL. Employees are the annual report's average and may cover a group.
Credit metrics are Dandex calculations from the filed figures, not filed values; estimates are in grey with a note. Ratios are percentages and gearing a multiple. Definitions. No cash flow statement filed (class A and B are exempt).
Annual report 2025
1 Jan 2025 to 31 Dec 2025, published 29 May 2026
Annual report 2024
1 Jan 2024 to 31 Dec 2024, published 26 Jun 2025
Annual report 2023
1 Jan 2023 to 31 Dec 2023, published 3 Jun 2024
Annual report 2022
1 Jan 2022 to 31 Dec 2022, published 29 Jun 2023
Annual report 2021
1 Jan 2021 to 31 Dec 2021, published 24 May 2022
Renescience A/S has new leadership, a good time to reach out.
Signal, a Dandex estimate. Lapses 18 Nov 2026.
Renescience A/S has changed ownership. A new strategy and new needs can be expected.
Signal, a Dandex estimate. Lapses 10 Dec 2026.
1 registered in CVR.
P-number 1014868913Kraftværksvej 53, 7000 Fredericia
